A Study to Test the Safety and Effectiveness of Nivolumab Combined With Daratumumab in Patients With Pancreatic, Non-Small Cell Lung or Triple Negative Breast Cancers, That Have Advanced or Have Spread

University Hospital of Lausanne, Lausanne

Local Institution, St Leonards

Klinik Fur Onkologie, Basel

Local Institution, Marseille

Local Institution, Milan

Hospital Gral. Univ. Gregorio Maranon, Madrid

Local Institution, Majadahonda - Madrid

Moffitt Cancer Center, Tampa

University Of Michigan, Ann Arbor

Centre Paul Strauss, Strasbourg

Universitaetsklinik Heidelberg, Heidelberg

Local Institution, Lyon

Medizinische Universitaetsklinik Freiburg, Freiburg im Breisgau

University Of Colorado, Aurora

Istituto Nazionale Tumori Fondazione Pascale, Napoli

Pacific Shores Medical Group, Long Beach

Providence Portland Medical Center, Portland

Local Institution, Edmonton

Universitaetsklinikum Carl Gustav Carus, Dresden

Fundacion De Investigacion, San Juan